Medtronic (MDT) has received CE mark for the Stealth AXiS surgical system. The Stealth AXiS system is indicated for spine and cranial procedures.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT:
- Medtronic announces milestones for Sphere-9, Sphere 360 catheters
- Medtronic announces FDA granted Breakthrough Device Designations to Sphere-9
- Medtronic price target lowered to $95 from $108 at Jefferies
- Medtronic: Portfolio Streamlining and Diabetes Spin-Off Benefits Offset by Lower Growth Outlook and Valuation Compression, Justifying Hold Rating
- Medtronic price target lowered to $90 from $104 at UBS